TBH Global Asset Management LLC Has $4.12 Million Stock Holdings in The Cigna Group (NYSE:CI)

TBH Global Asset Management LLC boosted its position in The Cigna Group (NYSE:CI) by 65.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,747 shares of the health services provider’s stock after buying an additional 5,451 shares during the quarter. The Cigna Group makes up about 0.8% of TBH Global Asset Management LLC’s portfolio, making the stock its 28th biggest position. TBH Global Asset Management LLC’s holdings in The Cigna Group were worth $4,117,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Fortitude Family Office LLC acquired a new position in The Cigna Group in the 4th quarter valued at $29,000. VisionPoint Advisory Group LLC increased its holdings in The Cigna Group by 112.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock worth $30,000 after purchasing an additional 55 shares in the last quarter. Pacifica Partners Inc. increased its holdings in The Cigna Group by 73.2% in the 4th quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider’s stock worth $43,000 after purchasing an additional 60 shares in the last quarter. MeadowBrook Investment Advisors LLC acquired a new position in The Cigna Group in the 4th quarter worth about $43,000. Finally, Cape Investment Advisory Inc. increased its holdings in The Cigna Group by 50.9% in the 3rd quarter. Cape Investment Advisory Inc. now owns 166 shares of the health services provider’s stock worth $47,000 after purchasing an additional 56 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Price Performance

The Cigna Group stock traded down $5.22 during midday trading on Friday, hitting $332.61. 1,303,058 shares of the company’s stock were exchanged, compared to its average volume of 1,585,104. The stock has a 50-day moving average price of $351.38 and a two-hundred day moving average price of $322.97. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $365.71. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The company has a market cap of $94.48 billion, a P/E ratio of 27.74, a PEG ratio of 1.03 and a beta of 0.57.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.17 by $0.30. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The firm had revenue of $57.25 billion during the quarter, compared to analysts’ expectations of $56.59 billion. During the same period in the prior year, the business earned $5.41 EPS. The company’s revenue for the quarter was up 23.2% compared to the same quarter last year. On average, equities research analysts forecast that The Cigna Group will post 28.47 earnings per share for the current year.

The Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be paid a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date is Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

Insider Activity

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total transaction of $2,073,429.66. Following the completion of the transaction, the senior vice president now owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 31,209 shares of the stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the completion of the transaction, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at approximately $123,618,339.18. The disclosure for this sale can be found here. In the last quarter, insiders sold 72,366 shares of company stock valued at $25,440,835. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Cantor Fitzgerald upped their price target on The Cigna Group from $384.00 to $400.00 and gave the company an “overweight” rating in a research report on Friday, May 3rd. Barclays assumed coverage on The Cigna Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price target on the stock. Wells Fargo & Company increased their price target on The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Oppenheimer increased their price target on The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $392.00 price target (up previously from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Two analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, The Cigna Group presently has a consensus rating of “Buy” and an average price target of $366.14.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.